Rett Syndrome Unknown Status Phase 2 Trials for Triheptanoin (DB11677)

Also known as: Rett's Syndrome / Rett's Disorder / RTT / Rett Disorder / Rett's disorder (disorder)

IndicationStatusPhase
DBCOND0002561 (Rett Syndrome)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03059160Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.Treatment
NCT02696044Treatment of Mitochondrial Dysfunction in Rett Syndrome With TriheptanoinTreatment